Court Tosses AstraZeneca's Challenge To USPTO's Fintiv Rule
A Virginia federal judge threw out a suit from pharmaceutical giant AstraZeneca that challenged a rule providing guidelines on whether the Patent Trial and Appeal Board should deny patent reviews due...To view the full article, register now.
Already a subscriber? Click here to view full article